Upcoming Webinar on April 24, 2026: Understanding Biomarkers in Sarcoma: How Testing Can Guide Treatment and Trial Options
Join us for the next Live Virtual Session with the Experts!
This session will provide an overview of biomarkers, what they are and how they are discovered and validated. During the session we will highlight the different types of biomarker tests used in sarcoma, how results are interpreted, and how this information can guide personalized treatment strategies.
As biomarker testing becomes more integrated into patient care, understanding biomarkers and how they can be used in treatment planning can help patients and families better navigate their treatment and clinical trial options.
Our expert speakers, Dr. Sandra D’Angelo (Sarcoma Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY) and Dr. Priya Chudasama (Precision Sarcoma Research, German Cancer Research Center, Heidelberg, Germany), will provide both clinical and research perspectives on how biomarker testing is used today and where the field is heading.